ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-0.39%
US Tech 100
21,476.00
-0.49%
S&P 500
6,117.52
-0.43%
US Dollar vs CAD
1.41709
-0.49%
Bitcoin
98,354.57
1.78%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GT Biopharma Inc (GTBP) Share Price

GT Biopharma Inc

GT Biopharma Inc (GTBP)

GT Biopharma Inc
2.13
0.02
(0.95%)
At close: February 20 3:00PM
Delayed by 15 minutes
2.13
0.00
( 0.00% )
After Hours: 3:02PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.13
Bid
2.08
Ask
2.29
Volume
7,791
2.07 Day's Range 2.2482
1.72 52 Week Range 10.6599
Market Cap
4.759M
Previous Close
2.11
Open
2.12
Last Trade
22
@
2.12
Last Trade Time
15:00:01
Financial Volume
US$ 16,723
VWAP
2.1465
Average Volume (3m)
518,689
Shares Outstanding
2,234,328
Dividend Yield
-
PE Ratio
-0.63
Earnings Per Share (EPS)
-3.4
Revenue
-
Net Profit
-7.6M

About GT Biopharma Inc

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.gtbiopharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was US$2.11. Over the last year, GT Biopharma shares have traded in a share price range of US$ 1.72 to US$ 10.6599.

GT Biopharma currently has 2,234,328 shares outstanding. The market capitalization of GT Biopharma is US$4.71 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.63.

Ask ADVFN Intelligence (AI)

GTBP Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
January 27 2025
GTBP (0.95%)

Form 8-K - Current report
Edgar (US Regulatory)
November 27 2024
GTBP (0.95%)

Form 8-K - Current report
Edgar (US Regulatory)
November 21 2024
GTBP (0.95%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 14 2024
GTBP (0.95%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
October 21 2024
GTBP (0.95%)

Form 8-K - Current report
Edgar (US Regulatory)
September 16 2024
GTBP (0.95%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1002.132.292.08192152.16343564CS
4-0.21-8.974358974362.342.482.01297472.1513058CS
12-0.74-25.78397212542.874.11.725186892.74125656CS
26-0.1-4.484304932742.234.11.722301112.73776971CS
52-2.27-51.59090909094.410.65991.724663996.04886605CS
156-81.87-97.4642857143841021.7227864716.29407246CS
260-162.87-98.7090909091165591.9931.7231040099.01522234CS

GTBP - Frequently Asked Questions (FAQ)

What is the current GT Biopharma share price?
The current share price of GT Biopharma is US$ 2.13
How many GT Biopharma shares are in issue?
GT Biopharma has 2,234,328 shares in issue
What is the market cap of GT Biopharma?
The market capitalisation of GT Biopharma is USD 4.71M
What is the 1 year trading range for GT Biopharma share price?
GT Biopharma has traded in the range of US$ 1.72 to US$ 10.6599 during the past year
What is the PE ratio of GT Biopharma?
The price to earnings ratio of GT Biopharma is -0.63
What is the reporting currency for GT Biopharma?
GT Biopharma reports financial results in USD
What is the latest annual profit for GT Biopharma?
The latest annual profit of GT Biopharma is USD -7.6M
What is the registered address of GT Biopharma?
The registered address for GT Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the GT Biopharma website address?
The website address for GT Biopharma is www.gtbiopharma.com
Which industry sector does GT Biopharma operate in?
GT Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
US$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
US$ 0.00
(0.00%)
0
AACGATA Creativity Global
US$ 0.00
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
US$ 0.00
(0.00%)
0
AACGATA Creativity Global
US$ 0.00
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
US$ 0.00
(0.00%)
0
AACGATA Creativity Global
US$ 0.00
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 0.00
(0.00%)
0

GTBP Discussion

View Posts
BurgerKing82 BurgerKing82 2 months ago
Hmmm... interesting
👍️0
glenn1919 glenn1919 2 months ago
GTBP................................................p/m
👍️0
philaya philaya 9 months ago
buy the dip....
low low.
👍️0
philaya philaya 9 months ago
Got in...
Happy losing day.
👍️0
TheFinalCD TheFinalCD 9 months ago
https://x.com/READY_2_PROFIT/status/1792903871624327515
👍️0
tw0122 tw0122 9 months ago
Didn’t participate in earlier todays squeeze but 100,000 shares available only. Nice continuation
👍️0
TheFinalCD TheFinalCD 9 months ago
GTBP https://x.com/GBearTrading/status/1792907456361713969
👍️0
Awl416 Awl416 9 months ago
LOL
👍️0
Monksdream Monksdream 9 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Awl416 Awl416 9 months ago
Wils
👍️0
Invest-in-America Invest-in-America 9 months ago
Regarding @RONN, no tip was given to me about it at all --- indeed, the FIRST time I heard about was from YOUR post to me over here.
👍️0
Invest-in-America Invest-in-America 9 months ago
GTBP: Nope; I simply follow the daily posts of iHub's "tw0122", who was the first to post in here on this one.
👍️0
reena969 reena969 9 months ago
I've been trying to find you Did you take the tip that was given to you?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174447373
👍️0
govprs govprs 9 months ago
Joker!!! Looks like it’s halted again
👍️0
bwrbad bwrbad 9 months ago
no future - be at 50c
👍️0
Invest-in-America Invest-in-America 9 months ago
GTBP: Halted!!
👍️0
govprs govprs 9 months ago
I’m still holding what’s all the excitement about
👍️0
Invest-in-America Invest-in-America 9 months ago
GTBP: Still holding --- 4-bagger later today??????
👍️0
tw0122 tw0122 9 months ago
Moon man summary 90% institutional ownership by Girozentrale on 1m float leaves 100,000 shares for retail to pump. June catalyst
👍️0
Otis T Otis T 11 months ago
One year price target of $153. Published post split, article available on NASDAQ.com.
👍️0
Muhbruh Muhbruh 11 months ago
https://twitter.com/StocksGambino/status/1767630737845391730
👍️0
Renee Renee 1 year ago
GTBP: effective Feb. 5,2024 a one for 30 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
👍️0
Plummy Potter Plummy Potter 1 year ago
Anyone have access to the latest HCW or EF Hutton research reports?
👍️0
Triple nickle Triple nickle 2 years ago
Nice grab
👍️0
limer814 limer814 2 years ago
Sure is ,and this sudden burst in volume is telling, added today
👍️0
Triple nickle Triple nickle 2 years ago
This is the bottom folks
👍️0
Triple nickle Triple nickle 2 years ago
Weeee
👍️0
Triple nickle Triple nickle 2 years ago
A little bit
👍️0
limer814 limer814 2 years ago
Action!!
👍️0
limer814 limer814 2 years ago
The big three 0
👍️ 1
SittingPretty SittingPretty 2 years ago
saw that too. these bios are beat to hell... should eventually get back some public trust
👍️0
limer814 limer814 2 years ago
Nice buys coming in
👍️0
SittingPretty SittingPretty 2 years ago
Nice! Should be hearing something from these guys... hopefully soon.
👍️0
limer814 limer814 2 years ago
Nice buys coming in
👍️0
SittingPretty SittingPretty 2 years ago
Regret not waiting... what a crap show lol
👍️0
SittingPretty SittingPretty 2 years ago
Have to admit, grateful to accumulate at these prices. $GTBP is far along in its process with FDA and others obviously know it. That $175k Form 4 purchase filing last week was telling!
https://www.otcmarkets.com/filing/html?id=16743896&guid=2aT-knKRHtwfJth
👍️0
SittingPretty SittingPretty 2 years ago
Good morning $GTBP
👍️0
diskman diskman 2 years ago
Very interesting
👍️ 1
SittingPretty SittingPretty 2 years ago
Good Morning Did you see this? Think we're getting close to some good news. Check it out:

Charles Casamento - Executive Director & Principal - The Sage Group purchased $175k worth of $GTBP @ .35 on 6/16/2023. Filed Form 4 on 06/21/2023
https://www.otcmarkets.com/filing/html?id=16743896&guid=-HT-kenyprHRB3h

Charles J. Casamento is currently Executive Director and Principal of The Sage Group, a healthcare advisory group specializing in mergers, acquisitions, and partnerships between biotechnology companies and pharmaceutical companies, since 2007.
https://www.linkedin.com/in/charles-casamento-b1a9173
👍️0
SittingPretty SittingPretty 2 years ago
Wow, L2 going crazy. Hopefully this is the flush out and then ready for higher ground!
👍️0
SittingPretty SittingPretty 2 years ago
Absolutely! Grabbed a bunch a few mins ago. Wow! What a pullback.
👍️0
Triple nickle Triple nickle 2 years ago
Another day of adding here
👍️0
SittingPretty SittingPretty 2 years ago
Nice! I'm right here with ya loading Good day for it!
👍️0
limer814 limer814 2 years ago
Loaded some more today
👍️0
SittingPretty SittingPretty 2 years ago
Great loading day!
👍️0
WARHAMMER WARHAMMER 2 years ago
Lol
👍️0
Triple nickle Triple nickle 2 years ago
Prosperity favors the bold
Can’t never could and won’t never will
👍️ 1
WARHAMMER WARHAMMER 2 years ago
Sounds Dam good to me :)
👍️0
WARHAMMER WARHAMMER 2 years ago
??!!
👍️0
Triple nickle Triple nickle 2 years ago
First target 1.12 second one 4.77
👍️0

Your Recent History

NASDAQ
GTBP
GT Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads